# Faeth Therapeutics, Inc.: filings

FTH · Nasdaq · CIK 1829802 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fth.md) · [Financials](/companies/fth/financials.md) · [Filings](/companies/fth/filings.md) · [Insiders](/companies/fth/insiders.md)

## Reports and events: 126 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 198, 8-K 84, 3 31, 10-Q 17, 4/A 13, DEFA14A 9, 144 8, CORRESP 7, SC 13D/A 7, SCHEDULE 13G 7, 10-K 6, S-8 6, DEF 14A 5, ARS 4, SC 13G/A 4, SCHEDULE 13G/A 4, EFFECT 3, S-3/A 3, SC 13G 3, UPLOAD 3, 10-K/A 2, 3/A 2, 424B5 2, 8-A12B 2, PRE 14A 2, S-3 2, SC 13D 2, 424B4 1, 8-K/A 1, CERT 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1, SEC STAFF LETTER 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 07:33 ET | [8-K](/filings/0001193125-26-432688.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-432688 |
| 2026-09-17 | 16:15 ET | [8-K](/filings/0001193125-26-394360.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-394360 |
| 2026-08-04 | 07:40 ET | [10-Q](/filings/0001193125-26-331562.md) | Quarterly report, period 2026-06-30 | 0001193125-26-331562 |
| 2026-08-04 | 07:40 ET | [8-K](/filings/0001193125-26-331563.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331563 |
| 2026-07-23 | 17:15 ET | [8-K](/filings/0001193125-26-314591.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-314591 |
| 2026-06-18 | 17:13 ET | [8-K](/filings/0001193125-26-276093.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276093 |
| 2026-06-15 | 08:16 ET | [8-K](/filings/0001193125-26-270330.md) | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-270330 |
| 2026-06-10 | 16:21 ET | [8-K](/filings/0001193125-26-265879.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-265879 |
| 2026-06-02 | 09:01 ET | [10-K/A](/filings/0001193125-26-252637.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-252637 |
| 2026-05-22 | 16:01 ET | [8-K](/filings/0001193125-26-236820.md) | 8.01 Other events | 0001193125-26-236820 |
| 2026-05-21 | 17:12 ET | [8-K](/filings/0001193125-26-234882.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234882 |
| 2026-05-15 | 07:40 ET | [10-Q](/filings/0001193125-26-225333.md) | Quarterly report, period 2026-03-31 | 0001193125-26-225333 |
| 2026-05-15 | 07:35 ET | [8-K](/filings/0001193125-26-225323.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-225323 |
| 2026-04-27 | 16:19 ET | [DEF 14A](/filings/0001193125-26-182143.md) | Proxy statement, period 2026-06-10 | 0001193125-26-182143 |
| 2026-04-16 | 16:02 ET | [8-K](/filings/0001193125-26-158951.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-158951 |
| 2026-04-15 | 16:15 ET | [8-K/A](/filings/0001193125-26-157038.md) | 9.01 Financial statements and exhibits | 0001193125-26-157038 |
| 2026-03-30 | 17:35 ET | [10-K](/filings/0001193125-26-132014.md) | Annual report, period 2025-12-31 | 0001193125-26-132014 |
| 2026-03-30 | 07:35 ET | [8-K](/filings/0001193125-26-130419.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-130419 |
| 2026-02-18 | 08:45 ET | [8-K](/filings/0001193125-26-056135.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-056135 |
| 2026-02-13 | 17:29 ET | [8-K](/filings/0001193125-26-051815.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-051815 |
| 2025-12-23 | 17:00 ET | [8-K](/filings/0001193125-25-331113.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-331113 |
| 2025-11-14 | 07:45 ET | [10-Q](/filings/0001193125-25-281590.md) | Quarterly report, period 2025-09-30 | 0001193125-25-281590 |
| 2025-11-14 | 07:35 ET | [8-K](/filings/0001193125-25-281581.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-281581 |
| 2025-10-30 | 09:05 ET | [8-K](/filings/0001193125-25-257621.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-257621 |
| 2025-10-17 | 08:05 ET | [8-K](/filings/0001193125-25-242007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-242007 |
| 2025-08-05 | 16:30 ET | [10-Q](/filings/0000950170-25-103101.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103101 |
| 2025-08-05 | 07:31 ET | [8-K](/filings/0001193125-25-173043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-173043 |
| 2025-07-09 | 16:30 ET | [8-K](/filings/0001193125-25-157113.md) | 3.01 Delisting notice | 0001193125-25-157113 |
| 2025-06-13 | 07:33 ET | [8-K](/filings/0001193125-25-140329.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-140329 |
| 2025-05-23 | 08:00 ET | [8-K](/filings/0001193125-25-125484.md) | 5.07 Shareholder vote results | 0001193125-25-125484 |
| 2025-05-06 | 16:30 ET | [10-Q](/filings/0000950170-25-064525.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064525 |
| 2025-05-06 | 07:35 ET | [8-K](/filings/0001193125-25-113299.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-113299 |
| 2025-04-11 | 08:00 ET | [DEF 14A](/filings/0000950170-25-053033.md) | Proxy statement, period 2025-05-21 | 0000950170-25-053033 |
| 2025-03-28 | 07:45 ET | [10-K](/filings/0000950170-25-046338.md) | Annual report, period 2024-12-31 | 0000950170-25-046338 |
| 2025-03-28 | 07:36 ET | [8-K](/filings/0001193125-25-066261.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-066261 |
| 2025-03-27 | 17:20 ET | [8-K](/filings/0001193125-25-065634.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-065634 |
| 2025-01-07 | 17:18 ET | [8-K](/filings/0001193125-25-002920.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-25-002920 |
| 2024-11-14 | 08:03 ET | [10-Q](/filings/0000950170-24-126748.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126748 |
| 2024-11-14 | 07:35 ET | [8-K](/filings/0001193125-24-258006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-258006 |
| 2024-10-30 | 16:30 ET | [8-K](/filings/0001193125-24-247599.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-247599 |
| 2024-09-20 | 16:31 ET | [8-K](/filings/0001193125-24-222937.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-222937 |
| 2024-08-06 | 16:30 ET | [10-Q](/filings/0000950170-24-091895.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091895 |
| 2024-08-06 | 07:36 ET | [8-K](/filings/0001193125-24-194428.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-194428 |
| 2024-07-12 | 16:31 ET | [8-K](/filings/0001193125-24-178607.md) | 3.01 Delisting notice | 0001193125-24-178607 |
| 2024-06-27 | 17:01 ET | [8-K](/filings/0001193125-24-170690.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-170690 |
| 2024-06-13 | 16:45 ET | [8-K](/filings/0001193125-24-160769.md) | 5.07 Shareholder vote results | 0001193125-24-160769 |
| 2024-06-03 | 07:31 ET | [8-K](/filings/0001193125-24-152363.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-152363 |
| 2024-05-23 | 17:10 ET | [8-K](/filings/0001193125-24-146093.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-146093 |
| 2024-05-09 | 16:31 ET | [10-Q](/filings/0000950170-24-057106.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057106 |
| 2024-05-09 | 07:37 ET | [8-K](/filings/0001193125-24-134767.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134767 |

Page 1 of 3. [Older](/companies/fth/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:18 ET. No prices; not investment advice.